The artificial insemination industry in Europe is rapidly growing, driven by increasing demand for fertility treatments and reproductive health solutions. Companies range from biotech startups to established healthcare providers, offering innovative technologies like at-home fertility kits and supportive therapies to combat infertility. This sector is expanding as more individuals pursue their reproductive choices and seek accessible medical solutions, particularly those relating to assisted reproductive technologies. In addition, advancements in AI and telemedicine are reshaping the market, enabling more personalized care and services to meet the desires and needs of an evolving patient base.


This list features a range of investors, including venture capital firms and corporate investors, all with a focus on the artificial insemination industry. Based in key locations across Europe such as Paris, London, and Vienna, these investors range from small teams to those managing large portfolios. Founded between 2004 and 2020, they participated in a total of 193 funding rounds in 2024, indicating a robust interest in supporting innovation within the reproductive health space.


Top 15 Artificial Insemination Investors in Europe


1. Bpifrance French Tech Accélération


Bpifrance French Tech Accélération is a venture capital firm based in Paris, Île-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through various services, including direct funding, export credit insurance, and private equity investments. The firm aims to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. Among its notable transactions, Bpifrance led a €7.5 million Series A round for Igyxos, a biotech startup, and co-led a $25 million Series B funding for May Health, which is developing Ovarian Rebalancing therapy to address infertility related to PCOS. These investments highlight Bpifrance's commitment to advancing healthcare solutions, particularly in the reproductive health sector.


2. Calm/Storm

  • Website: calmstorm.vc
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2020
  • Headcount: 1-10
  • Number of deals in 2024: 13
  • LinkedIn: calm-storm

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm focuses on early-stage investments in health tech startups, particularly those led by purpose-driven founders. They provide capital, support, and networking opportunities to help these companies thrive in the competitive health tech landscape. Notably, Calm/Storm has invested in Béa Fertility, a startup that raised $1 million in a pre-seed round to develop at-home fertility treatments, and has also participated in funding rounds for other reproductive health companies like Fertifa. Their portfolio reflects a commitment to addressing sensitive health issues, including fertility and reproductive health, making them a significant player in this sector.


3. Crowdcube

  • Website: crowdcube.com
  • Type: Corporate
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 2010
  • Headcount: 51-200
  • Number of deals in 2024: 3
  • LinkedIn: crowdcube-limited

Crowdcube is a corporate crowdfunding platform based in London, England, founded in 2010. It enables businesses, particularly startups and SMEs, to raise capital through equity investments by connecting them with potential investors. The platform emphasizes diversity and inclusion within its workforce and offers investment management services. Notably, Crowdcube has been involved in several transactions relevant to the artificial insemination industry, including Hertility Health, which raised over $2.5 million in April 2023, and Fertility Circle, which raised over $500,000 in May 2021. These investments highlight Crowdcube's commitment to supporting innovative companies in the fertility and reproductive health space.


4. Fresenius Netcare GMBH

  • Website: fresenius.com
  • Type: Corporate
  • Headquarters: Geisenheim, Hesse, Germany
  • Headcount: 10001+
  • LinkedIn: iteanova

Fresenius Netcare GMBH is a corporate investor based in Geisenheim, Hesse, Germany, and is part of Fresenius SE & Co. KGaA, a leading healthcare provider specializing in lifesaving medicines and technologies. The company operates through its subsidiaries, including Fresenius Kabi and Fresenius Helios, and is committed to enhancing healthcare access globally. Notably, Fresenius Helios acquired Eugin Group on December 21, 2020, for approximately $526 million. Eugin Group is a prominent player in the field of assisted reproductive technologies, including artificial insemination, which aligns with Fresenius's strategic interests in expanding its healthcare portfolio. Additionally, Fresenius has made other significant acquisitions in the healthcare sector, such as Quirónsalud, Spain's largest private hospital operator, further solidifying its position in the healthcare market.


5. Alma Angels

  • Website: alma-angels.com
  • Type: Corporate
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 2019
  • Headcount: 1-10
  • LinkedIn: alma-angels

Alma Angels is a not-for-profit angel investment community based in London, England, founded in 2019. The organization is dedicated to supporting women entrepreneurs by investing in women-led tech and IP-rich startups. They provide networking opportunities and resources to help these businesses thrive, aiming to break down barriers to capital access for women founders. Among their notable transactions, Alma Angels participated in the funding of Béa Fertility, a UK-based startup that offers 'fertility-as-a-service' solutions, which includes at-home fertility treatments. This investment highlights their commitment to the reproductive health sector. Additionally, they have been involved in other femtech and health-related startups, such as The Lowdown, a sexual and reproductive health platform, and Tuune, which focuses on women's health. These transactions reflect their broader interest in supporting innovations that enhance women's health and well-being.


6. Sofinnova Partners


Sofinnova Partners is a venture capital firm based in Paris, Île-De-France, France, specializing in life sciences investments. Founded in 1972, the firm focuses on supporting innovative healthcare startups through funding and strategic guidance, particularly in the biopharma and medtech sectors. In recent years, Sofinnova has been actively involved in transactions that are relevant to women's reproductive health. For instance, they led a $38 million Series A funding round for Freya Biosciences, which is dedicated to advancing women's reproductive immunotherapies. Additionally, they participated in a $25 million Series B funding round for May Health, a company developing Ovarian Rebalancing therapy to address infertility related to PCOS. These investments highlight Sofinnova's commitment to fostering scientific advancements in reproductive health, making them a relevant player in the artificial insemination industry.


7. M Ventures

  • Website: m-ventures.com
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Netherlands
  • Founded year: 2009
  • Headcount: 11-50
  • Number of deals in 2024: 18
  • LinkedIn: merck-ventures

M Ventures is a venture capital fund based in Amsterdam, Netherlands, founded in 2009. The firm specializes in investing in transformative ideas within the biotechnology and technology sectors, with a strong focus on healthcare and life sciences. M Ventures collaborates closely with entrepreneurs to drive innovation and growth in their portfolio companies. Among their notable transactions, M Ventures led a Series A financing round for Future Fertility, a company developing AI-enabled and non-invasive fertility solutions, including egg assessment software aimed at improving IVF success rates. This investment highlights M Ventures' commitment to supporting advancements in fertility technology. Additionally, while they have been involved in other healthcare investments, their focus on fertility-related innovations positions them as a relevant player in the artificial insemination industry.


8. Venrex

  • Website: venrex.partners
  • Type: Venture Capital
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 2002
  • Headcount: 11-50
  • Number of deals in 2024: 11
  • LinkedIn: venrex

Venrex is a venture capital firm based in London, specializing in early-stage investments in technology-enabled businesses within consumer industries. Founded in 2002, the firm provides funding and strategic support to help these businesses grow in competitive markets. Venrex has been involved in several notable transactions, particularly in the women's health sector. For instance, they participated in the seed funding round for Hertility Health, which raised GBP4.2 million to expand its product offerings and clinical trials, positioning itself as a key player in women's health education and services. Additionally, Venrex has invested in Maven Clinic, a telemedicine startup that focuses on women's health, including family planning and fertility services. These investments highlight Venrex's commitment to supporting innovative solutions in the health sector, particularly those that cater to women's reproductive health needs.


9. Octopus Ventures

  • Website: octopusventures.com
  • Type: Venture Capital
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 2008
  • Headcount: 51-200
  • Number of deals in 2024: 37
  • LinkedIn: octopus-ventures

Octopus Ventures is a venture capital firm based in London, UK, founded in 2008. They focus on backing founders and startups across various sectors, including B2B Software, Bio, Climate, Consumer, Deep Tech, Fintech, and Health. Notably, they have invested in Béa Fertility, a fertility tech startup that raised £2.5m to develop at-home fertility treatments, showcasing their commitment to the fertility and reproductive health market. This investment is significant as it aims to make clinical-grade fertility treatments accessible at home, which is directly relevant to artificial insemination. Additionally, they have shown interest in femtech through their investment in Tuune, further indicating their engagement in sectors that intersect with reproductive health.


10. Kima Ventures

  • Website: kimaventures.com
  • Type: Venture Capital
  • Headquarters: Paris, Île-De-France, France
  • Founded year: 2010
  • Headcount: 1-10
  • Number of deals in 2024: 50
  • LinkedIn: kima-ventures

Kima Ventures is a venture capital firm based in Paris, Île-De-France, France, founded in 2010. The firm specializes in investing in early-stage startups across various sectors, backing two startups per week with financial support and mentorship to help them navigate initial challenges and achieve success. Among their notable transactions, Kima Ventures invested in Contraline, which raised $3 million in a seed round in September 2018 and $680,000 in a pre-seed round in June 2016. Contraline is focused on developing innovative male contraceptive solutions, which aligns with the broader context of reproductive health and artificial insemination. Additionally, Kima Ventures has invested in other health-related startups, such as Qunomedical, a digital health platform, indicating their active engagement in the health sector.


11. Cathay Capital

  • Website: cathaycapital.com
  • Type: Private Equity
  • Headquarters: Paris, Île-De-France, France
  • Founded year: 2006
  • Headcount: 51-200
  • Number of deals in 2024: 10
  • LinkedIn: cathay-capital

Cathay Capital is a private equity investment firm based in Paris, Île-De-France, France, founded in 2006. The firm specializes in private equity, venture capital, and healthcare investments, focusing on supporting companies in scaling their operations globally and sustainably. They provide capital and expertise to help entrepreneurs and management teams navigate market challenges across various industries. Notably, Cathay Capital has been involved in transactions such as IMV Technologies, which raised funds in 2010 and is known for its work in animal reproduction technologies, including artificial insemination. This involvement highlights their interest in the reproductive technology sector. Additionally, they have invested in companies like Meiyou and Shandong Sinder Technology, further showcasing their diverse investment strategy while maintaining a foothold in healthcare-related ventures.


12. Ferring Pharmaceuticals


Ferring Pharmaceuticals is a biopharmaceutical company founded in 1950, headquartered in Saint-Prex, Vaud, Switzerland. The company specializes in reproductive health, maternal health, gastroenterology, and urology, developing innovative treatments aimed at improving the quality of life for patients. Notably, Ferring has been involved in significant transactions such as the acquisition of BioSET in 2015, which may enhance their capabilities in reproductive technologies. Additionally, they participated in a substantial funding round for FerGene in 2019, indicating their active role in the biopharmaceutical landscape. Their focus on reproductive health positions them as a key player in the artificial insemination industry.


13. Salica Investments


Salica Investments is a venture capital firm based in London, England, founded in 2017. The firm specializes in private market funds that focus on equity and debt investments, catering to institutional investors, family offices, and individual investors. Salica emphasizes sustainability and ESG practices in its investment approach, aiming to deliver strong returns while fostering positive change. Notably, Salica has participated in funding rounds for ExSeed Health, a company dedicated to fertility and reproductive health, raising significant amounts in seed rounds. Additionally, they have invested in Peppy, a health services platform that provides support for various health needs, including reproductive health. These transactions highlight Salica's engagement in sectors that align with artificial insemination and reproductive health, reinforcing their relevance in this investment category.


14. Speedinvest

  • Website: speedinvest.com
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2011
  • Headcount: 51-200
  • Number of deals in 2024: 45
  • LinkedIn: speedinvest

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help these companies scale. Their investment focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Recently, Speedinvest has made notable investments in the reproductive health space, including a seed funding round for Fertifa, a startup dedicated to reproductive health, and The Lowdown, a platform focused on sexual and reproductive health. These transactions highlight Speedinvest's commitment to supporting innovations in the reproductive health sector, making them a relevant player in the artificial insemination industry.


15. Seed Capital Denmark

  • Website: seedcapital.dk
  • Type: Venture Capital
  • Headquarters: Frederiksberg, Frederiksberg, Denmark
  • Founded year: 2004
  • Headcount: 1-10
  • Number of deals in 2024: 5
  • LinkedIn: seed-capital-denmark

Seed Capital Denmark is a venture capital firm based in Copenhagen, specializing in providing seed funding and advisory services to technology startups in Denmark. Founded in 2004, the firm has a strong focus on sectors such as SaaS and Fintech, but it has also invested in companies within the biotechnology space. Notably, they have been involved in transactions with companies like EmbryoTrans Biotech, which operates in the artificial insemination sector, as well as SwimCount and Observe Medical, which may have applications in reproductive health. This diverse portfolio showcases Seed Capital's commitment to supporting innovative solutions in various fields, including those related to artificial insemination.



Artificial Insemination Insights: Key Investors in Europe


InvestorHeadquarterSizeFoundedDeals 2024
Bpifrance French Tech AccélérationParis, Île-De-France, France1-102015198
Calm/StormVienna, Vienna, Austria1-10202013
CrowdcubeLondon, England, United Kingdom (UK)51-20020103
Fresenius Netcare GMBHGeisenheim, Hesse, Germany10001+0
Alma AngelsLondon, England, United Kingdom (UK)1-1020190
Sofinnova PartnersParis, Île-De-France, France51-200197225
M VenturesAmsterdam, North Holland, Netherlands11-50200918
VenrexLondon, England, United Kingdom (UK)11-50200211
Octopus VenturesLondon, England, United Kingdom (UK)51-200200837
Kima VenturesParis, Île-De-France, France1-10201050
Cathay CapitalParis, Île-De-France, France51-200200610
Ferring PharmaceuticalsSaint-Prex, Vaud, Switzerland5001-1000019500
Salica InvestmentsLondon, England, United Kingdom (UK)51-200201715
SpeedinvestVienna, Vienna, Austria51-200201145
Seed Capital DenmarkFrederiksberg, Frederiksberg, Denmark1-1020045


Want to find more investors focusing on the artificial insemination industry?

If you want to find more investors that are active in the artificial inseminationindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!